Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wander AG is a Swiss company with a storied history in the pharmaceutical and nutritional industries, most notably recognized for the discovery and development of the landmark antipsychotic clozapine (Leponex). Founded in 1865 by Dr. Georg Wander, the company initially focused on malt-based nutritional products like Ovomaltine before expanding into a major pharmaceutical enterprise. Its pharmaceutical division was acquired by Sandoz in 1967, eventually becoming a core part of Novartis, while its food and beverage operations were later sold to Associated British Foods. Today, Wander remains an active entity in the consumer health and nutrition space, maintaining its headquarters in Switzerland and continuing to produce globally recognized health-oriented food brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wander.